Related Experiment Video
Updated: Jan 3, 2026

Ex Situ Normothermic Machine Perfusion of Donor Livers
Published on: May 26, 2015
Cardiac Dysfunction in Patients with Liver Cirrhosis
Niyanta Karki1, Sudhamshu Kc1, Dilip Sharma1
1Department of Medicine, Liver Unit, Bir hospital, Kathmandu, Nepal.
Insights
Cardiac dysfunction, particularly diastolic dysfunction, is common in cirrhosis patients. Prolonged QTc interval may signal early cardiac issues and correlates with liver disease severity.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Cirrhosis complications like ascites and varices are well-known.
- Cardiac dysfunction in cirrhosis is under-recognized but significantly impacts morbidity and mortality.
- This dysfunction is often asymptomatic at rest, manifesting during stress or interventions.
Purpose of the Study:
- To investigate the prevalence and characteristics of cardiac dysfunction in patients with cirrhosis.
- To assess the relationship between cardiac dysfunction and liver disease severity.
- To identify potential early indicators of cardiac dysfunction in cirrhotic patients.
Main Methods:
- Cross-sectional study conducted at Bir Hospital's Liver Unit (May 2015-May 2016).
- Diagnosis of cirrhosis confirmed via clinical, lab, ultrasound, endoscopic, and/or biopsy data.
- Cardiac function assessed using resting pulse, mean arterial pressure, ECG, and 2D echocardiography; liver function evaluated with Child-Pugh and MELD scores.
Main Results:
- Diastolic dysfunction observed in 61.9% of patients, more frequent in alcoholic cirrhosis.
- Systolic dysfunction noted in 6.6% of alcoholic patients.
- 51.4% met criteria for cirrhotic cardiomyopathy; 79% exhibited prolonged QTc interval (>0.44s), especially in Child-Pugh C and MELD >10.
Conclusions:
- Cardiac dysfunction, primarily diastolic, is prevalent in cirrhosis, irrespective of the cause.
- QTc prolongation may serve as an early marker for cardiac dysfunction in cirrhosis.
- QTc prolongation correlates directly with Child-Pugh and MELD scores, indicating severity.
Background:
The clinical picture in cirrhosis is dominated by the classical complications such as ascites, bleeding varices, portal hypertension and encephalopathy. Cardiac dysfunction in patients with cirrhosis, which contributes significantly to the morbidity and, mortality though prevalent, is less studied and not widely recognized entity since it is largely asymptomatic at rest, with overt heart failure seen mainly during pharmacological stress, transjugular intrahepatic portosystemic shunt, liver transplantation.
Methods:
It is a cross sectional study done on patients admitted in wards or attending to outpatient department of Liver unit, Bir Hospital, between May 2015 to May 2016. Diagnosis of cirrhosis was based on clinical examination, lab parameters, ultrasound examination, endoscopy and/or liver biopsy. Cirrhotic patients after assessing the exclusion criteria were recruited for the study. Child Pugh and model for end stage liver disease scores were calculated to assess the liver function. Cardiac function was evaluated by resting pulse, mean arterial pressure, electrocardiography, and 2 dimensional echocardiography.
Results:
Diastolic dysfunction was seen in 61.9%(48) and was more common in alcoholic group (63.2% Vs 58.6%). Systolic dysfunction was seen in 6.6% of alcoholic patients only. 51.4% had cirrhotic cardiomyopathy according to the criteria (proposed by World congress of gastroenterology in 2005). Prolonged QTc of >0.44 seconds was noted in 79%, mainly in child pugh C, with model for end stage liver disease score >10.
Conclusions:
Cardiac dysfunction is prevalent with sizeable number of patients with cirrhosis especially in the form of diastolic dysfunction independent of etiology. QTc prolongation might be an early indicator of cardiac dysfunction and is directly correlated with child pugh and model for end stage liver disease scores.
More Related Videos
09:37Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...